Subacute Therapeutic Dosing of Artemether-Lumefantrine and Artesunate-Amodiaquine Combination Preserves Plasma Cholesterol, Renal Antioxidant Status, and Organ Weights in Rats

Recent instances of breakdowns of malaria control programs and the constant emergence of drug-resistant parasites to monotherapies have shored up the use of artemisinin-based combination therapy (ACT) as the malaria therapy of choice. We evaluated a subacute therapeutic dosing of artemether-lumefant...

Descripción completa

Detalles Bibliográficos
Autores principales: Otuechere, Chiagoziem A., Edewor, Gloria, Kale, Oluwafemi Ezekiel, Ekor, Martins
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400373/
https://www.ncbi.nlm.nih.gov/pubmed/22848861
http://dx.doi.org/10.1155/2012/257986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400373/
https://www.ncbi.nlm.nih.gov/pubmed/22848861
http://dx.doi.org/10.1155/2012/257986

Ejemplares similares